Thursday, August 25, 2016

LUPIN's SUBSIDIARY RECEIVES US FDA APPROVAL

Lupin's US subsidiary, Gavis Pharmaceuticals LLC., U.S.A.has received final approval for its Linezolid® Tablets, 600 mg from the United States Food and Drug Administration (FDA) to market a generic equivalent of Pharmacia & Upjohn Company's Zyvox® Tablets, 600 mg. Linezolid® Tablets, 600 mg are the AB rated generic equivalent of Pharmacia & Upjohn Company's Zyvox® Tablets, 600 mg. 

It is indicated in adults and children for the treatment of certain infections caused by susceptible Gram-positive bacteria. 

No comments:

Post a Comment